June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

Why Cenovus Energy Shares Are Trading Higher Today

Published 27/04/2022, 20:52
© Reuters.  Why Cenovus Energy Shares Are Trading Higher Today
CVE
-

  • Cenovus Energy Inc (NYSE: CVE) (TSX: CVE) reported a first-quarter basic EPS of C$0.81 compared to C$0.10 in 1Q21.
  • Q1 total revenues increased to C$16.2 billion from C$13.7 billion in the previous quarter, driven by higher average realized sales prices for the company's products across the Upstream and Downstream businesses.
  • The total operating margin was C$3.5 billion, compared with C$2.6 billion in Q4.
  • The Canadian Manufacturing segment had crude utilization of 89% and throughput of 98,100 bbls/d, compared with 98% and 108,300 bbls/d in Q4.
  • In the U.S. Manufacturing segment, crude utilization of 80% and throughput of 403,700 bbls/d were both up from 72% and 361,600 bbls/d in Q4.
  • Total upstream production of ~800,000 barrels of oil equivalent per day (BOE/d).Total downstream throughput of 502,000 barrels per day (bbls/d).
  • Cenovus Energy reported C$1.4 billion cash from operating activities, C$2.6 billion adjusted funds flow, and C$1.8 billion free funds flow.
  • CVE reduced total long-term debt to C$11.7 billion and net debt to C$8.4 billion as of March 31, 2022. It expects to reach its interim net debt target of below C$8 billion imminently.
  • The company's Board of Directors approved tripling the base dividend starting with Q2 and a plan for additional increases to shareholder returns. The base dividend will increase from C$0.14 to C$0.42 per share annually.
  • Cenovus will target to return 50% of quarterly excess free funds flow to shareholders when reported net debt is less than C$9 billion.
  • Dividend: The Board declared a dividend of C$0.105 per share, payable on June 30, 2022, to common shareholders of record as of June 15, 2022.
  • Price Action: CVE shares are trading higher by 10.15% at C$23.18 on TSX and higher by 10.11% at $18.14 on NYSE on the last check Wednesday.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.